Mindfulness smartphone program plus counseling and nicotine replacement to help cancer survivors quit smoking
Official title: Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors
Run by Rutgers, The State University of New Jersey · NCT07210567 · Data updated 2026-11-12
This project will try a mindfulness smartphone app together with brief face-to-face counseling and nicotine replacement to help cancer survivors who smoke quit.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (New Brunswick, New Jersey) |
| Status | Recruiting |
| Started | January 27, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | May 4, 2026 |
| Trial ID | NCT07210567 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a cancer diagnosis who have smoked at least once in the past 30 days, are motivated to quit within 30 days, can read English, and own a smartphone that can install the app are ideal candidates.
✕Probably not a fit
People already enrolled in a cessation program, currently using cessation medications, with active psychosis, who are pregnant or breastfeeding, or who lack a compatible smartphone are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, two-arm feasibility trial will deliver a mindfulness-based ecological momentary intervention via a smartphone app alongside brief in-person cessation counseling and nicotine replacement therapy, compared with a quitline-based approach. The study enrolls adult cancer survivors who currently smoke and are motivated to quit within the next 30 days and requires participants to own a compatible smartphone. Primary aims are feasibility and acceptability, with outcomes including app engagement, adherence to counseling and nicotine replacement, and preliminary quit-related measures. The trial is conducted at Rutgers' Institute for Nicotine & Tobacco Studies in New Brunswick, New Jersey, with collaboration from the National Cancer Institute.
Why it matters
Potential benefit: If successful, this approach could give cancer survivors an accessible, on-the-go mindfulness tool combined with counseling and nicotine replacement to improve quit rates.
How similar studies have gone: Previous smartphone and mindfulness-based interventions for smoking have shown promising but mixed results in general populations, and combining ecological momentary mindfulness with standard counseling for cancer survivors is a relatively new approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥18 years old * smoked ≥1 cigarette per day (even one or two puffs) within the past 30 days * having been diagnosed with cancer * being motivated to quit in the next 30 days * having a valid home address and functioning phone number * being able to read, write, and speak English * having a smartphone that allows installation of the app * willingness to download the app Exclusion Criteria: * being enrolled in a smoking cessation program * current use of smoking cessation medications * evidence of current psychosis * current/planning pregnancy or lactation
Where it's running
-
Institute for Nicotine & Tobacco Studies
New Brunswick, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Min-Jeong Yang, PhD — Rutgers, The State University of New Jersey
- Study coordinator: Rutgers IRB/Human Research Protection Program
- Email: irboffice@research.rutgers.edu
- Phone: 9739723608
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Quitting Matters: a smoking quit program for people living with HIV
This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.
-
Smoky Futures: Danish Adolescent Nicotine Use over Time
This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.
-
Nicotine Orodispersible Tablet to Relieve Cravings in Smokers
A nicotine mint orodispersible tablet is tested vs placebo to see if it quickly eases the urge to smoke in adult cigarette smokers.
-
Optimizing when weekly chatbot reminders go out to people using a chatbot for quitting smoking
This study tests whether sending weekly reminders at different times helps people stay engaged with a chatbot smoking-cessation service.
-
NMDA and Sigma-1 combination therapy for smoking cessation with AXS-05
This phase 3 trial tests whether AXS-05 can help adults quit smoking better than placebo or bupropion.
-
AI-assisted interactive case-based training to improve smoking cessation counseling by medical interns
This study tests whether AI-powered interactive case-based training helps medical interns provide better smoking cessation counseling.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.